|
|
Article: New technology for fetal testing: research is being carried out into whether non-invasive prenatal diagnosis can be used to test for conditions currently only confirmed via invasive methods.(Fetal Testing)(Report)
- Article from:
- Royal College of Midwives Journal
- Article date:
- April 1, 2009
CopyrightCOPYRIGHT 2009 Royal College of Midwives. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Development of noninvasive prenatal diagnosis (NIPD) has resulted from several new techniques studying free fetal nucleic acids, which may allow a diagnosis of certain fetal conditions by taking blood from the mother. In special circumstances, the NHS has used this new technology in determining rhesus status of the fetus in rhesus disease and determining fetal sex in sex-linked conditions.
Further research is being carried out to determine whether this technology could be used to diagnose certain genetic and chromosomal conditions such as Trisomy 21 (Down's syndrome). Thus invasive procedures such as an amniocentesis or chorionic villus sampling (CVS) and the ...
Related newspaper, magazine, and journal articles:
|
|
Article: Larger Columns and Change of Lysis Buffer Increase the Yield of ...
Clinical Chemistry;
January 1, 2006 ;
700+ words
... ... Bond, Karen Krajewski, and Dyanna Lincoln, for their generous support in obtaining AF samples. [Reference] References 1. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum ...
|
|